ArticleCell death & disease2025

SOX5 inhibition overcomes PARP inhibitor resistance in BRCA-mutated breast and ovarian cancer.

Mithun Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.